We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Roxana Mehran

Roxana Mehran MD

Professor of Medicine, Cardiology and Health Evidence and Policy, Director of Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI, Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes; Professor of Medicine in Cardiology, and Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai is an internationally renowned interventional cardiologist, and clinical research expert in the field of cardiovascular disease. As Director of the Center for Interventional Cardiovascular Research and Clinical Trials at Mount Sinai, she has built a globally respected academic research center focused on developing randomized clinical trials, outcomes research projects and high impact academic publications. A prolific researcher, she has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, participates regularly in developing clinical guidelines, and has authored >900 peer-reviewed articles. She has been included in Clarivate Analytics: The most influential scientific minds as one of the highly cited researchers for several consecutive years. She is a founder and Chief Scientific Officer of the Cardiovascular Research Foundation (CRF) and recently founded Women as One, an independent nonprofit organization dedicated to advancing opportunities for women in medicine. Very active within professional organizations, Dr. Mehran has been the Chair of the Interventional Council for the American College of Cardiology (ACC); Program Chair of the 2016 Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), where she is also a co-founder of the Women in Innovations (WIN) Committee; and is a member of the American Heart Association's (AHA) Go Red for Women Scientific Advisory Group. Prior to Mount Sinai, Dr. Mehran held appointments at Columbia University Medical Center, Lenox Hill Hospital, and Washington Hospital Center. She completed fellowships in cardiovascular disease and interventional cardiology at Mount Sinai Medical Center. Dr. Mehran is a recipient of several awards including the 2016 American College of Cardiology Bernadine Healy Leadership in CV disease award, the 2018 Nanette Wenger Award from Women’s Heart for excellence in research and education and the 2019 Ellis Island Medal of Honor.

Disclosures

Dr. Mehran reports institutional research grants from Abbott Laboratories, AstraZeneca, Bayer, Beth Israel Deaconess, Bristol Myers Squibb, CERC, Chiesi, Concept Medical, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich; consultant fees from Abbott Laboratories, Boston Scientific, Janssen Scientific Affairs, Medscape/WebMD, Medtelligence (Janssen Scientific Affairs), Roivant Sciences, Sanofi, Siemens Medical Solutions; consultant fees paid to the institution from Abbott Laboratories, Bristol-Myers Squibb; advisory board, funding paid to the institution from Spectranetics/Philips/Volcano Corp; consultant (spouse) from Abiomed, The Medicines Company; Equity <1% from Claret Medical, Elixir Medical; DSMB Membership fees paid to the institution from Watermark Research Partners; consulting (no fee) from Idorsia Pharmaceuticals Ltd., Regeneron Pharmaceuticals. Associate Editor for ACC, AMA.